Lee & Man Chemical Company Limited (0746.HK)
HKD 3.67
(-1.61%)
HKD 3.67
(-1.61%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 588.88 Million HKD | -19.91% |
| 2022 | 735.3 Million HKD | -3.68% |
| 2021 | 763.37 Million HKD | 32.0% |
| 2020 | 578.32 Million HKD | 2.07% |
| 2019 | 566.61 Million HKD | -0.91% |
| 2018 | 571.81 Million HKD | 46.0% |
| 2017 | 391.65 Million HKD | 31.71% |
| 2016 | 297.37 Million HKD | -6.14% |
| 2015 | 316.82 Million HKD | 30.58% |
| 2014 | 242.62 Million HKD | 111.71% |
| 2013 | 114.6 Million HKD | -36.88% |
| 2012 | 181.55 Million HKD | -9.22% |
| 2011 | 199.99 Million HKD | -24.73% |
| 2010 | 265.69 Million HKD | 64.44% |
| 2009 | 161.57 Million HKD | 17.48% |
| 2008 | 137.53 Million HKD | 18.91% |
| 2007 | 115.66 Million HKD | 8.64% |
| 2006 | 106.46 Million HKD | 0.0% |
| 2004 | 197.17 Million HKD | -12.97% |
| 2003 | 226.57 Million HKD | 16.19% |
| 2002 | 195 Million HKD | 39.4% |
| 2001 | 139.88 Million HKD | 23.34% |
| 2000 | 113.41 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 267.5 Million HKD | 0.0% |
| 2023 Q4 | 279.88 Million HKD | 0.0% |
| 2023 FY | 588.88 Million HKD | -19.91% |
| 2023 Q2 | 308.99 Million HKD | 0.0% |
| 2022 Q2 | 396.81 Million HKD | 0.0% |
| 2022 FY | 735.3 Million HKD | -3.68% |
| 2022 Q4 | 338.48 Million HKD | 0.0% |
| 2021 Q2 | 344.65 Million HKD | 0.0% |
| 2021 FY | 763.37 Million HKD | 32.0% |
| 2021 Q4 | 418.71 Million HKD | 0.0% |
| 2020 Q2 | 249.07 Million HKD | 0.0% |
| 2020 FY | 578.32 Million HKD | 2.07% |
| 2020 Q4 | 329.24 Million HKD | 0.0% |
| 2019 Q2 | 261.62 Million HKD | 0.0% |
| 2019 FY | 566.61 Million HKD | -0.91% |
| 2019 Q4 | 304.98 Million HKD | 0.0% |
| 2018 Q2 | 241.93 Million HKD | 0.0% |
| 2018 FY | 571.81 Million HKD | 46.0% |
| 2018 Q4 | 329.88 Million HKD | 0.0% |
| 2017 FY | 391.65 Million HKD | 31.71% |
| 2017 Q2 | 178.86 Million HKD | 0.0% |
| 2017 Q4 | 212.78 Million HKD | 0.0% |
| 2016 Q2 | 124.48 Million HKD | 0.0% |
| 2016 Q4 | 172.88 Million HKD | 0.0% |
| 2016 FY | 297.37 Million HKD | -6.14% |
| 2015 Q2 | 91.59 Million HKD | 0.0% |
| 2015 FY | 316.82 Million HKD | 30.58% |
| 2015 Q4 | 225.22 Million HKD | 0.0% |
| 2014 Q4 | 170.24 Million HKD | 0.0% |
| 2014 Q2 | 72.38 Million HKD | 0.0% |
| 2014 FY | 242.62 Million HKD | 111.71% |
| 2013 Q4 | 110.47 Million HKD | 0.0% |
| 2013 FY | 114.6 Million HKD | -36.88% |
| 2013 Q2 | 4.12 Million HKD | 0.0% |
| 2012 Q3 | 18.87 Million HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2012 FY | 181.55 Million HKD | -9.22% |
| 2012 Q4 | - HKD | -100.0% |
| 2011 FY | 199.99 Million HKD | -24.73% |
| 2011 Q4 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2010 FY | 265.69 Million HKD | 64.44% |
| 2010 Q2 | - HKD | 0.0% |
| 2010 Q4 | - HKD | 0.0% |
| 2009 FY | 161.57 Million HKD | 17.48% |
| 2009 Q4 | - HKD | 0.0% |
| 2008 FY | 137.53 Million HKD | 18.91% |
| 2008 Q4 | - HKD | 0.0% |
| 2007 FY | 115.66 Million HKD | 8.64% |
| 2006 FY | 106.46 Million HKD | 0.0% |
| 2004 FY | 197.17 Million HKD | -12.97% |
| 2003 FY | 226.57 Million HKD | 16.19% |
| 2002 FY | 195 Million HKD | 39.4% |
| 2001 FY | 139.88 Million HKD | 23.34% |
| 2000 FY | 113.41 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 35.87 Million HKD | -1541.534% |